Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Russo

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Nutrients|October 6, 2020
The Role of Diet on Insulin SensitivityMaria Mirabelli, Diego Russo, Antonio Brunetti
Cancers|January 13, 2019
Reading Cancer: Chromatin Readers as Druggable Targets for Cancer TreatmentCatia Mio, Stefania Bulotta, Diego Russo, et al.
Expert Opinion on Investigational Drugs|February 15, 2011
XL184 (cabozantinib) for medullary thyroid carcinomaCosimo Durante, Diego Russo, Antonella Verrienti, et al.
Endocrine|December 23, 2015
Emerging strategies for managing differentiated thyroid cancers refractory to radioiodineStefania Bulotta, Marilena Celano, Giuseppe Costante, et al.
Current Opinion in Oncology|October 11, 2019
Novel therapeutic options for radioiodine-refractory thyroid cancer: redifferentiation and beyondStefania Bulotta, Marilena Celano, Giuseppe Costante, et al.
Drug Delivery and Translational Research|March 20, 2015
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapyDonato Cosco, Donatella Paolino, Jessica Maiuolo, et al.
Oncology Reports|December 15, 2010
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cellsCinzia Puppin, Nadia Passon, Alessandra Franzoni, et al.
Trends in Endocrinology and Metabolism: TEM|March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinomaEfisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Oncology Letters|December 30, 2017
Effects of HuR downregulation on anaplastic thyroid cancer cellsLorenzo Allegri, Catia Mio, Diego Russo, et al.
Journal of Molecular Endocrinology|February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targetsDiego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Nutrients|October 6, 2020
The Role of Diet on Insulin SensitivityMaria Mirabelli, Diego Russo, Antonio Brunetti
Cancers|January 13, 2019
Reading Cancer: Chromatin Readers as Druggable Targets for Cancer TreatmentCatia Mio, Stefania Bulotta, Diego Russo, et al.
Expert Opinion on Investigational Drugs|February 15, 2011
XL184 (cabozantinib) for medullary thyroid carcinomaCosimo Durante, Diego Russo, Antonella Verrienti, et al.
Endocrine|December 23, 2015
Emerging strategies for managing differentiated thyroid cancers refractory to radioiodineStefania Bulotta, Marilena Celano, Giuseppe Costante, et al.
Current Opinion in Oncology|October 11, 2019
Novel therapeutic options for radioiodine-refractory thyroid cancer: redifferentiation and beyondStefania Bulotta, Marilena Celano, Giuseppe Costante, et al.
Drug Delivery and Translational Research|March 20, 2015
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapyDonato Cosco, Donatella Paolino, Jessica Maiuolo, et al.
Oncology Reports|December 15, 2010
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cellsCinzia Puppin, Nadia Passon, Alessandra Franzoni, et al.
Trends in Endocrinology and Metabolism: TEM|March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinomaEfisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Oncology Letters|December 30, 2017
Effects of HuR downregulation on anaplastic thyroid cancer cellsLorenzo Allegri, Catia Mio, Diego Russo, et al.
Journal of Molecular Endocrinology|February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targetsDiego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Pageof 12